Division of Metabolic and Endocrine Drug Products
Review Teams

The review team includes the following:

• Project Manager, Consumer Safety Officer - The primary contact with the sponsor  (updated 10/28/2004)
• Medical Officer - The leader of the Review Team (updated 10/28/2004)
• Pharmacologist- Reviews all nonclinical studies.
• Chemist - Co-located with our Division. (updated 10/28/2004)
• Statistician- Co-located with our Division
• Clinical Pharmacology / Biopharmaceutic- reviewer Co-located with our Division
  

The following groups may also be consulted during the review process:

• The Endocrinologic and Metabolic Drugs Advisory Committee
• The Nonprescription Drug Advisory Committee
• The Drug Abuse Potential Advisory Committee
• The Carcinogenicity Assessment Committee
• Division of Drug Marketing, Advertising, and Communications
  
  
  You can click on any of the underlined disciplines listed above to see a list of the reviewers names and their areas of specialty.
  

Back to Top     DMEDP Home

Date created: October 28, 2004

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research